BAY 73-4506, BAY 734506
22551
Phase 2 small_molecule active
Quick answer
BAY 73-4506, BAY 734506 for Solid malignant tumors is a Phase 2 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Solid malignant tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active